The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Androgen deprivation therapy and overall survival for Gleason 8 versus Gleason 9-10 prostate cancer.
 
David Dewei Yang
No Relationships to Disclose
 
Brandon Arvin Virgil Mahal
No Relationships to Disclose
 
Vinayak Muralidhar
No Relationships to Disclose
 
Neil E. Martin
Consulting or Advisory Role - Via Oncology
 
Peter F. Orio
No Relationships to Disclose
 
Kent William Mouw
No Relationships to Disclose
 
Martin T. King
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
Quoc-Dien Trinh
No Relationships to Disclose
 
Karen E. Hoffman
No Relationships to Disclose
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - Dendreon
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; Dendreon; EMD Serono; Ferring; GenomeDx; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Paul L. Nguyen
Stock and Other Ownership Interests - Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Bayer; Biogen (I); Dendreon; Ferring; GenomeDx; GigaGen (I); Infinity Pharmaceuticals (I); Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring